NHI-Glc-2

N/A

Report date: 2025/03/20 16:12:39
NME

Base Information

Drug NameNHI-Glc-2
Drug Alias Nameglucose conjugated LDH-A inhibitor (VU University Medical Center/University of Illinois at Urbana-Champaign/Universita di Pisa)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionL-lactate dehydrogenase A chain degraders
TargetsL-lactate dehydrogenase A chain
Therapy Area/IndicationsPancreatic NeoplasmsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesNetherlandsItaly
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Illinois At Urbana–Champaign
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of PisaUniversity Of Illinois At Urbana–ChampaignVu University Medical Center
Inactive CompaniesN/A
Active IndicationsPancreatic NeoplasmsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A